Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
Is A Rise Imminent For Guardant Health Stock After A 38% Fall In A Month?
08:00am, Wednesday, 21'st Dec 2022
Guardant Health stock (NASDAQ: GH), a healthcare company that offers non-invasive cancer diagnosis tests, has seen a fall of 38% in a month, while it's down 70% this year.
Guardant Health Drops 30% as Cancer Test Disappoints
06:17pm, Friday, 16'th Dec 2022
On Dec. 15, the highly anticipated results of Guardant Health Inc.'s ( GH , Financial) pivotal DNA blood test trial were revealed, and the results fell short of expectations, causing the company's sto
Guardant Health stock plunges, Exact Sciences rises on contrasting colorectal cancer detection tests
10:58am, Friday, 16'th Dec 2022
Guardant Health Inc (NASDAQ:GH) stock plunged on Friday after the firm released results from a study of its colon cancer blood test that showed disappointing accuracy rates. Although the test accurate
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results
09:57am, Friday, 16'th Dec 2022
Guardant Health (NASDAQ: GH ) stock dropped nearly 33% after a test of its colon-cancer screening system disappointed investors. The company's Shield blood test found 83% of cancers and 13% of pre-ca
Guardant Claimed Success for Its Colon Cancer Blood Test. Investors Disagreed.
10:19pm, Thursday, 15'th Dec 2022
“We just launched a rocket and got it to the moon,” said co-chief executive Helmy Eltoukhy. “It's illogical, irrational, and people don't understand the science.
Guardant Health stock plunges, Exact Sciences stock soars after colorectal-cancer test study results
05:28pm, Thursday, 15'th Dec 2022
Shares of Guardant Health Inc. tanked 40% and shares of Exact Sciences Corp. rallied more than 25% in the extended session Thursday after Guardant announced results from a study using its blood test t
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares? - Exact Sciences (NASDAQ:EXAS)
05:23pm, Thursday, 15'th Dec 2022
Guardant Health Inc GH and Exact Sciences Corp EXAS shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.
Guardant Health, Inc. (GH) Q3 2022 Earnings Call Transcript
10:52pm, Thursday, 03'rd Nov 2022
Guardant Health, Inc. (NASDAQ:GH ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Alex Kleban - Vice President, Investor Relations Helmy Eltoukhy - Co-Chief Executiv
Guardant Health (GH) Reports Q3 Loss, Lags Revenue Estimates
08:21pm, Thursday, 03'rd Nov 2022
Guardant Health (GH) delivered earnings and revenue surprises of -24.41% and 0.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Guardant Health Stock Fell 5.5% Today
12:02pm, Wednesday, 19'th Oct 2022
Is Guardant Health as obvious a bargain as this analyst makes it out to be?
Guardant Health to Report Third Quarter 2022 Financial Results on November 3, 2022
04:05pm, Monday, 10'th Oct 2022
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2022 after market c
Why Guardant Health Topped the Market on Thursday
06:02pm, Thursday, 06'th Oct 2022
Add another name to the list of the cancer-diagnostic company's bulls.
Why Guardant Health Crushed the Market Today
06:40pm, Wednesday, 31'st Aug 2022
The company deepened its relationship with an important peer.
Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference
04:05pm, Monday, 29'th Aug 2022
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will be participating in the upcoming Morgan Stanley Global Healthcare
Why Guardant Health Stock Was So Healthy Today
05:31pm, Friday, 05'th Aug 2022
Investors are cheered by the company's latest set of quarterly results, in spite of a deeper net loss.
